USPTO serial 88573422
NINEMETERS BIOPHARMA
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- EISNACH, MICHAEL PATRICK
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with NINEMETERS BIOPHARMA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Devon E. White
Devon E. White WYRICK ROBBINS YATES & PONTON LLP4101 LAKE BOONE TRAIL, SUITE 300RALEIGH, NC 27607UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical and biological preparations for the treatment of anorectal diseases and gastrointestinal and liver disorders; Targeted pharmacological and biological treatments for anorectal diseases, liver, and gastrointestinal disorders such as fecal incontinence, pruritus ani, and radiation proctitis; Prescription and non-prescription pharmacological and biological treatments administered in various pharmaceutical technological forms namely, in solid form pills, tablets, capsules, caplets, sachets, in semi-liquid form namely, gels, ointments and pastes, suppositories, in liquid form namely, drops, injectables, infusions, in gaseous form namely, inhalants, or in sprays, namely, intranasally administered medications, for the treatment of anorectal diseases and gastrointestinal illnesses and disorders; Capsules sold empty for pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Suppositories with proprietary delivery system for the precise delivery of drugs that target conditions and diseases of the anorectal region; Suppositories | ACTIVE | — |
| 042 | Pharmaceutical research and development services; Medical and scientific research information in the field of novel pharmaceutical discovery and development; Research and development in the pharmaceutical and biotechnology fields; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Medical and scientific research, namely, conducting clinical trials for others of New Therapeutic Entities (NTEs) defined as pharmacological treatments based on molecules that are already approved for other indications that are neither New Chemical Entities (NCEs) nor generics and New Chemical Entities (NCEs) and Biologic License Application (BLAs) as novel pharmaceutical treatments; Research and development in the field of New Therapeutic Entities (NTEs) defined as pharmacological treatments based on molecules that are already approved for other indications that are neither New Chemical Entities (NCEs) nor generics and New Chemical Entities (NCEs) and Biologic License Application (BLAs) as novel pharmaceutical treatments; Research and development in the field of novel pharmaceutical treatments and clinical trials; Providing medical and scientific research information in the field of novel pharmaceutical treatments and clinical trials; Clinical trials services for others | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by RDD Pharma, Inc.
- Other trademarks owned by RDD Pharma, Inc.
- Other trademarks owned by 9 METERS BIOPHARMA
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named NINEMETERS BIOPHARMA
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 27, 2023 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Mar 27, 2023 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Aug 13, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 12, 2022 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Aug 12, 2022 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Aug 4, 2022 | EXT5 | SOU EXTENSION 5 FILED | — |
| Aug 4, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 15, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 11, 2022 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Feb 11, 2022 | EXT4 | SOU EXTENSION 4 FILED | — |
| Feb 11, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 22, 2021 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Aug 20, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 18, 2021 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Aug 18, 2021 | EXT3 | SOU EXTENSION 3 FILED | — |
| Aug 18, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 12, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 10, 2020 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Dec 10, 2020 | EXT2 | SOU EXTENSION 2 FILED | — |
| Dec 10, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 15, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 13, 2020 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Aug 13, 2020 | EXT1 | SOU EXTENSION 1 FILED | — |
| Aug 13, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 18, 2020 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 24, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 24, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 4, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 18, 2019 | ALIE | ASSIGNED TO LIE | — |
| Nov 14, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 14, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 14, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 14, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 14, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 14, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 14, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 14, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 7, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 26, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 13, 2019 | NWAP | NEW APPLICATION ENTERED | — |